210 related articles for article (PubMed ID: 10779141)
1. Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients.
Pittas AG; Adler M; Fazzari M; Tickoo S; Rosai J; Larson SM; Robbins RJ
Thyroid; 2000 Mar; 10(3):261-8. PubMed ID: 10779141
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
4. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
[TBL] [Abstract][Full Text] [Related]
5. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer.
Qiu ZL; Song HJ; Xu YH; Luo QY
J Clin Endocrinol Metab; 2011 Oct; 96(10):3078-86. PubMed ID: 21795449
[TBL] [Abstract][Full Text] [Related]
7. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables.
Ruegemer JJ; Hay ID; Bergstralh EJ; Ryan JJ; Offord KP; Gorman CA
J Clin Endocrinol Metab; 1988 Sep; 67(3):501-8. PubMed ID: 3410936
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma.
Schlumberger M; Tubiana M; De Vathaire F; Hill C; Gardet P; Travagli JP; Fragu P; Lumbroso J; Caillou B; Parmentier C
J Clin Endocrinol Metab; 1986 Oct; 63(4):960-7. PubMed ID: 3745409
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features and prognosis in 104 colorectal cancer patients with bone metastases].
Hong RX; Lin QJ; Luo J; Dai Z; Wang WN
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):787-91. PubMed ID: 24378104
[TBL] [Abstract][Full Text] [Related]
10. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
11. Long-term results in elderly patients with differentiated thyroid carcinoma.
Vini L; Hyer SL; Marshall J; A'Hern R; Harmer C
Cancer; 2003 Jun; 97(11):2736-42. PubMed ID: 12767085
[TBL] [Abstract][Full Text] [Related]
12. Incidence and prognostic factors of Japanese breast cancer patients with bone metastasis.
Oka H; Kondoh T; Seichi A; Hozumi T; Nakamura K
J Orthop Sci; 2006 Jan; 11(1):13-9. PubMed ID: 16437343
[TBL] [Abstract][Full Text] [Related]
13. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
14. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases].
Xu DL; Zhang XT; Wang GH; Li FB; Hu JY
Ai Zheng; 2005 Nov; 24(11):1404-7. PubMed ID: 16552972
[TBL] [Abstract][Full Text] [Related]
16. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
[TBL] [Abstract][Full Text] [Related]
17. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas.
Bernier MO; Leenhardt L; Hoang C; Aurengo A; Mary JY; Menegaux F; Enkaoua E; Turpin G; Chiras J; Saillant G; Hejblum G
J Clin Endocrinol Metab; 2001 Apr; 86(4):1568-73. PubMed ID: 11297585
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of papillary and follicular thyroid carcinoma.
Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
[TBL] [Abstract][Full Text] [Related]
19. Papillary and follicular thyroid carcinomas with bone metastases: a series of 39 cases during a period of 18 years.
Fanchiang JK; Lin JD; Huang MJ; Shih HN
Changgeng Yi Xue Za Zhi; 1998 Dec; 21(4):377-82. PubMed ID: 10074721
[TBL] [Abstract][Full Text] [Related]
20. [Natural history and development of bone metastasis. Apropos of 429 cases].
Conroy T; Malissard L; Dartois D; Luporsi E; Stines J; Chardot C
Bull Cancer; 1988; 75(9):845-57. PubMed ID: 3207894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
